ESSENTIAL ISR

Angiographic and optical coherence tomography assessment of the new drug-eluting balloon ESSENTIAL for the treatment of In-Stent Restenosis.

Device: essential

Number of patients: 33

Follow up: 24-month

Essential ISR was presented at EuroPCR 2019.

In this study, the drug-coated balloon essential showed a good efficacy in the treatment of ISR (mostly of DES) in terms of OCT and QCA assessment, which appear to be comparable to the provided by other drug-coated balloons well supported by clinical evidence.

Clinical efficacy seems to be good and maintained on the very long term.

 

Essential ISR was presented at EuroPCR 2019.

José M. de la Torre Hernandez – Universitary Hospital Marqués de Valdecilla, (Santander, SPA).

All clinicals trials at iVascular
ESSENTIAL in Small Vessels Registry